Literature DB >> 3074117

Shigella.

H L DuPont1.   

Abstract

Shigella strains capable of producing illness possess a 140 megadalton plasmid that determines its property of epithelial cell penetration. In the classic presentation, there is a descending intestinal tract infection beginning with the passage of small numbers of large-volume stools and progressing to the passage of many small-volume stools that contain blood and mucus. Shigellae are efficiently transmitted to contacts in person-to-person spread and only 200 viable cells are sufficient to produce illness in susceptible persons. Shigellosis should be suspected in persons with severe diarrhea, in those with fever, when bloody stools are passed, or when stool smears contain many leukocytes. The current treatment of choice is TMP-SMX or, in adults, a quinolone (norfloxacin or ciprofloxacin).

Entities:  

Mesh:

Year:  1988        PMID: 3074117

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  7 in total

1.  Microfluidic quantification of multiple enteric and opportunistic bacterial pathogens in roof-harvested rainwater tank samples.

Authors:  Warish Ahmed; Qian Zhang; Satoshi Ishii; Kerry Hamilton; Charles Haas
Journal:  Environ Monit Assess       Date:  2018-01-30       Impact factor: 2.513

2.  Cladophora (Chlorophyta) spp. harbor human bacterial pathogens in nearshore water of Lake Michigan.

Authors:  Satoshi Ishii; Tao Yan; Dawn A Shively; Muruleedhara N Byappanahalli; Richard L Whitman; Michael J Sadowsky
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Identification of Shigella flexneri subserotype 1c in rural Egypt.

Authors:  A El-Gendy; N El-Ghorab; E M Lane; R A Elyazeed; N I Carlin; M M Mitry; B A Kay; S J Savarino; L F Peruski
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Shigella spp. surveillance in Indonesia: the emergence or reemergence of S. dysenteriae.

Authors:  D Subekti; B A Oyofo; P Tjaniadi; A L Corwin; W Larasati; M Putri; C H Simanjuntak; N H Punjabi; J Taslim; B Setiawan; A A Djelantik; L Sriwati; A Sumardiati; E Putra; J R Campbell; M Lesmana
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

5.  Symptomatic Shigella sonnei urinary tract infection.

Authors:  C J Papasian; S Enna-Kifer; B Garrison
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

6.  Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992.

Authors:  S Ashkenazi; M May-Zahav; J Sulkes; R Zilberberg; Z Samra
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  Shigella flexneri perinephric abscess and bacteremia.

Authors:  Hussam Al-Soub; Mona Al-Maslamani; Jameela Al-Khuwaiter; Yasser El-Deeb; Sittana S El-Shafie
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.